Precigen, Inc. (PGEN)
NASDAQ: PGEN · IEX Real-Time Price · USD
1.595
+0.005 (0.31%)
Jul 22, 2024, 10:08 AM EDT - Market open
Precigen Employees
Precigen had 202 employees as of December 31, 2023. The number of employees decreased by 7 or -3.35% compared to the previous year.
Employees
202
Change (1Y)
-7
Growth (1Y)
-3.35%
Revenue / Employee
$26,926
Profits / Employee
-$479,743
Market Cap
406.37M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sonida Senior Living | 3,955 |
| Organogenesis Holdings | 862 |
| Cerus | 637 |
| Revance Therapeutics | 597 |
| AxoGen | 428 |
| Anika Therapeutics | 357 |
| Esperion Therapeutics | 240 |
| Lyell Immunopharma | 224 |
PGEN News
- 7 weeks ago - Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response - PRNewsWire
- 2 months ago - Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis Presented at the 2024 ASCO Annual Meeting - PRNewsWire
- 2 months ago - Precigen Reports First Quarter 2024 Financial Results and Business Updates - PRNewsWire
- 2 months ago - Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual Meeting - PRNewsWire
- 3 months ago - Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting - PRNewsWire
- 3 months ago - Actym Therapeutics Appoints Thomas Smart as CEO - PRNewsWire
- 4 months ago - Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th - PRNewsWire
- 4 months ago - Precigen Reports Full Year 2023 Financial Results and Business Updates - PRNewsWire